Tansi has several years of work experience from both industry and academia. Prior to being a postdoctoral researcher within FBMH at The University of Manchester, Tansi was part of the Drug Discovery Unit at Pfizer, Kent.

She is now responsible for identifying commercially viable Life Science projects and optimising them for real world impact.

 

Tansi's involvement

Life Sciences

Ravan Bio - Live longer and healthier

Ravan Bio is identifing and re-purposing combinations of existing drugs and nutraceuticals to treat age-related conditions by targeting senescent cells.
Covid-19, coronavirus | University of Manchester - Innovation Factory

Chemistry and PhysicsHealth and BiotechPhysical Sciences

Antiviral agents

With the devastating effects of the Covid-19 pandemic still being felt around the globe, there is an ever-greater need for antiviral protection. Broad-spectrum antiviral agents have the potential to destroy a wide range of viruses and can be used in a wide variety of applications beyond drug modalities. This new platform technology is suitable for incorporation into antiviral coatings and could therefore transform the practice of sterilisation forever.